Caplin Point Laboratories Limited
- Stock
- CAPLIPOINT
- NSE
- ₹2,301.30−0.02%
- Delayed close, 16 Oct
Details
- INE475E01026
- Healthcare
- Pharmaceuticals
- Face value ₹2
- Market cap ₹17,493 Cr
Paid for 17 years without a break
Dividend per share by FY
| Financial year | Total dividend |
|---|---|
| FY11 | ₹0.20 |
| FY12 | ₹0.30 |
| FY13 | ₹0.40 |
| FY14 | ₹0.50 |
| FY15 | ₹0.80 |
| FY16 | ₹1.50 |
| FY17 | ₹0.70 |
| FY18 | ₹1.50 |
| FY19 | ₹2.00 |
| FY20 | ₹4.30 |
| FY21 | ₹0.40 |
| FY22 | ₹3.00 |
| FY23 | ₹4.00 |
| FY24 | ₹4.50 |
| FY25 | ₹5.00 |
| FY26 | ₹6.00 |
| FY27 | ₹8.00 |
TTM payout
₹8.00
2 payouts in 12 months
Yield
0.35%
Dividend yield · trailing 12 months
52-wk closing range ₹1,504.80 – ₹2,867.40 · split-adjusted
Yield and payout totals recalculated 18 Oct 2026.
Recent payouts
· 25 on record since FY11| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 18 Sep 2026 | Final | same day | ₹4.00 |
| 29 May 2026 | Interim | 30 May 2026 | ₹4.00 |
| 12 Sep 2025 | Final | same day | ₹3.00 |
| 30 May 2025 | Interim | same day | ₹3.00 |
| 23 Sep 2024 | Final | same day | ₹2.50 |
Amounts marked * were restated for a later split or bonus so they compare with today’s shares. Switch to “as filed” to see what was actually declared at the time — that is the figure on an old broker statement.
Income calculator
₹344
Expected income per year, before tax, at the current 0.35% yield
≈ 43 shares at ₹2,301.30, using ₹98,956 of the ₹1,00,000. Based on the last twelve months’ payouts — not a forecast, and dividends are taxed at your own slab rate.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.